SlideShare una empresa de Scribd logo
1 de 88
Anti-diabetic Agents Florencia D. Munsayac, MD, FPSECP, MBA, RMT
 
The Endocrine Pancreas 1 million islets of Langerhans ,[object Object],[object Object],[object Object],[object Object],[object Object]
Diabetes Mellitus ,[object Object],[object Object],[object Object],[object Object],Type 2 Diabetes - blood glucose levels rise due to  1) Lack of insulin production 2) Insufficient insulin action (resistant cells) - commonly detected after 40 - eventually leads to β-cell failure  (resulting in insulin dependence) ,[object Object],[object Object],[object Object],Type 4 Diabetes (Gestational Diabetes)   3-5% of pregnant women in the US develop gestational diabetes
Diabetes Mellitus ,[object Object],[object Object],[object Object],[object Object]
Diabetes – Insulin (synthesis, storage, secretion) This light micrograph of a section of the human pancreas shows one of the islets of Langerhans,  center,  a group of modified glandular cells. These cells secrete insulin, a hormone that helps the body metabolize sugars, fats, and starches. The blue and white lines in the islets of Langerhans are blood vessels that carry the insulin to the rest of the body.
Diabetes – Insulin (synthesis, storage, secretion) Insulin  is a small protein consisting of an  A  chain of 21 amino acids linked by two disulfide (S—S) bridges to a   B  chain of 30 amino acids. Beta cells have channels in their plasma membrane that serve as glucose detectors. Beta cells secrete insulin in response to a rising level of circulating glucose .
Diabetes – Insulin (synthesis, storage, secretion) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diabetes – Insulin (synthesis, storage, secretion)
Diabetes – Insulin (synthesis, storage, secretion) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diabetes – Insulin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diabetes – Insulin (Biochemical Role) ,[object Object],[object Object],[object Object],[object Object]
Effects of Insulin on its Targets ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],protein synthesis amino acids u ptake glucose uptake glycogen  synthesis enzyme production glycogen breaking fat  synthesis
Effects of Insulin on its Targets Transporters Tissues GlucoseKm (Mmo/L)  Function GLUT 1 All tissues, esp.red cells, brain 1-2 Basal uptake of glucose; Transport across the BBB GLUT 2 B cells of pancreas; Liver; kidney; gut 15-20  Regulation of insulin release, other aspects of glucose homeostasis GLUT 3 Brain, kidney, placenta, other tissues < 1 Uptake into neurons, other tissues GLUT 4 Muscle, adipose 5 Insulin-mediated uptake of glucose GLUT 5 Gut, kidney  1-2 Absorption of fructose
Diabetes - Insulin Receptor ,[object Object],[object Object]
Principal Types and Duration of Action ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Principal Types and Duration of Action ,[object Object],6-7 hrs 2 hrs 10-20 min HIRI 3-5 hrs 1hr 5-15 min Insulin glulysine 3-5 hrs 1 hr 5-15 min Insulin aspart 3-5 hrs 1 hr 5-15 min Insulin lispro Duration Peak Onset Rapid-acting insulin
Principal Types and Duration of Action ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Principal Types and Duration of Action ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Principal Types and Duration of Action ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Principal Types and Duration of Action ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Species of Insulin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Delivery Systems   A.   Portable Pen Injectors - to facilitate multiple SQ injections    B. Continuous Subcutaneous Insulin Infusion Devices (CSII, Insulin Pumps) - encouraged for individuals who are unable to obtain target control  while on multiple injection regimens & where excellent glycemic control is desired, such as during pregnancy - velosulin (reg. insulin) & insulin aspart and lispro   C.   Inhaled Insulin - have a rapid route and a relatively short duration of  action - used to cover mealtime insulin requirements  - to correct high glucose levels  
Factors that Affect Insulin Absorption: -      site of injection: abdomen, buttock, anterior thigh, or dorsal  arm -      type of insulin -      subcutaneous blood flow: massage, hot baths, or exercise -      smoking -      regional muscular activity at the site of the injection -      volume & concentration of injected insulin -      depth of injection  
Complications of Insulin Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Complications of Insulin Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Insulin Secretagogues: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Biguanides ,[object Object],[object Object],[object Object],[object Object],[object Object]
Biguanides ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Biguanides ,[object Object],[object Object],[object Object],[object Object]
Biguanides ,[object Object],[object Object],[object Object]
Biguanides ,[object Object],[object Object],[object Object],[object Object]
Thiazolidinediones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Thiazolidinediones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Thiazolidinediones ,[object Object],[object Object],[object Object],[object Object]
Thiazolidinediones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Thiazolidinediones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Alpha-Glucosidase Inhibitors ,[object Object],[object Object],[object Object]
Alpha-Glucosidase Inhibitors ,[object Object],[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   ,[object Object],[object Object]
Pathophysiology of Type 2 Diabetes Insulin Resistance ,[object Object],[object Object]
Pathophysiology of Type 2 Diabetes  Beta cell defect ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   Other Factors ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   The Glucagon Factor ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   The Glucagon Factor ,[object Object],[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   The Gastric Emptying Factor ,[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   One last observation ,[object Object],[object Object],[object Object],[object Object]
What are incretins? ,[object Object],[object Object],[object Object]
What are incretins? Gastric Inhibitory Polypeptide (GIP)   ,[object Object]
What are incretins?   Glucagon-like peptide-1 (GLP-1)   ,[object Object],[object Object],[object Object]
Actions of GLP-1 ,[object Object],[object Object],[object Object],[object Object],[object Object]
Actions of GLP-1 ,[object Object],[object Object],[object Object],[object Object]
Actions of GLP-1 ,[object Object]
Actions of GLP-1   The Problem ,[object Object]
The Solution ,[object Object],[object Object],[object Object]
Incretin mimetics Exenatide   ,[object Object],[object Object],[object Object],[object Object]
 
Incretin mimetics Exenatide ,[object Object],[object Object],[object Object],[object Object]
 
Weight Loss With Exenatide   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Nausea With Exenatide   ,[object Object],[object Object]
Incretin mimetics   Recent Advances ,[object Object],[object Object]
Dipeptidyl Peptidase-IV Antagonists   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dipeptidyl Peptidase-IV Antagonists   Sitagliptin and Vildagliptin ,[object Object],[object Object],[object Object],[object Object]
Dipeptidyl Peptidase-IV Antagonists   Recent Advances ,[object Object],[object Object]
Newer Agent ,[object Object],[object Object],[object Object],[object Object],[object Object]
Newer Agent ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object]
THANK YOU
Insulin Drug Evolution ,[object Object],[object Object]
Insulin Drug Evolution ,[object Object],Recombinant DNA technology has also made it   possible   to manufacture slightly-modified forms of human insulin   that work faster (Humalog® and NovoLog®) or slower   (Lantus®) than regular human insulin.
 

Más contenido relacionado

La actualidad más candente

Insulin preparations
Insulin preparationsInsulin preparations
Insulin preparations
eckotanglao
 

La actualidad más candente (20)

INSULIN & ITS PREPARATIONS
INSULIN & ITS PREPARATIONSINSULIN & ITS PREPARATIONS
INSULIN & ITS PREPARATIONS
 
Calcium channel blockers - Medicinal chemistry for B.Pharm.
Calcium channel blockers - Medicinal chemistry for B.Pharm.Calcium channel blockers - Medicinal chemistry for B.Pharm.
Calcium channel blockers - Medicinal chemistry for B.Pharm.
 
Bioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , OxytocinBioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , Oxytocin
 
Insulin & Oral Hypoglycemic Agents.
Insulin & Oral Hypoglycemic Agents.Insulin & Oral Hypoglycemic Agents.
Insulin & Oral Hypoglycemic Agents.
 
Pp oral hypoglycemic agents
Pp oral hypoglycemic agentsPp oral hypoglycemic agents
Pp oral hypoglycemic agents
 
5th unit anti- diabetic agents
5th unit anti- diabetic agents5th unit anti- diabetic agents
5th unit anti- diabetic agents
 
Antineoplastic agents
Antineoplastic agentsAntineoplastic agents
Antineoplastic agents
 
Pharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsPharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugs
 
Industrial production estimation and utilization of artemisinin
Industrial production estimation and utilization of artemisininIndustrial production estimation and utilization of artemisinin
Industrial production estimation and utilization of artemisinin
 
Insulin preparations
Insulin preparationsInsulin preparations
Insulin preparations
 
Anti Arrhythmic Drugs
Anti Arrhythmic DrugsAnti Arrhythmic Drugs
Anti Arrhythmic Drugs
 
Antidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistryAntidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistry
 
Cardiac glycosides
Cardiac glycosidesCardiac glycosides
Cardiac glycosides
 
Oral hypoglycemic agents
Oral hypoglycemic agentsOral hypoglycemic agents
Oral hypoglycemic agents
 
Types of parenteral formulations
Types of parenteral formulationsTypes of parenteral formulations
Types of parenteral formulations
 
Tablets formulation
Tablets formulationTablets formulation
Tablets formulation
 
Class drug therapy of shock
Class drug therapy of shockClass drug therapy of shock
Class drug therapy of shock
 
Diuretics
DiureticsDiuretics
Diuretics
 
Congestive heart failure (chf) medicinal chemistry
Congestive heart failure (chf) medicinal chemistryCongestive heart failure (chf) medicinal chemistry
Congestive heart failure (chf) medicinal chemistry
 
Expt 9 Effect of drugs on rabbit eye
Expt 9  Effect of drugs on rabbit eyeExpt 9  Effect of drugs on rabbit eye
Expt 9 Effect of drugs on rabbit eye
 

Destacado

Destacado (6)

abdominal wall
abdominal wallabdominal wall
abdominal wall
 
Git review
Git reviewGit review
Git review
 
Gulteal region
Gulteal regionGulteal region
Gulteal region
 
PADUA'S BONES,MUSCLES, AND JOINTS QUESTIONS
PADUA'S BONES,MUSCLES, AND JOINTS QUESTIONSPADUA'S BONES,MUSCLES, AND JOINTS QUESTIONS
PADUA'S BONES,MUSCLES, AND JOINTS QUESTIONS
 
Neoplasia review
Neoplasia reviewNeoplasia review
Neoplasia review
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 

Similar a Antidiabetic agents1dated

Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
JIMMYALEX8
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
Manu1418
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
Manu1418
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
Manu1418
 
Periop management of diabetes
Periop management of diabetesPeriop management of diabetes
Periop management of diabetes
deepmbbs04
 

Similar a Antidiabetic agents1dated (20)

diabetes
diabetes diabetes
diabetes
 
anti diabetics [Autosaved] final.pdf
anti diabetics [Autosaved]    final.pdfanti diabetics [Autosaved]    final.pdf
anti diabetics [Autosaved] final.pdf
 
Insulin 2020
Insulin 2020Insulin 2020
Insulin 2020
 
Insulin
InsulinInsulin
Insulin
 
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
Anti diabetic agents,Medicinal Chemistry,Mr.Jimmy Alexander ,Associate Profes...
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
 
Insulin22
Insulin22Insulin22
Insulin22
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
 
Insulin recent updates final
Insulin recent updates finalInsulin recent updates final
Insulin recent updates final
 
Anti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptxAnti-Diabetic Drugs ppt.pptx
Anti-Diabetic Drugs ppt.pptx
 
Periop management of diabetes
Periop management of diabetesPeriop management of diabetes
Periop management of diabetes
 
Drugs for Diabetes Mellitus
Drugs for Diabetes MellitusDrugs for Diabetes Mellitus
Drugs for Diabetes Mellitus
 
Glucose regulation
Glucose regulationGlucose regulation
Glucose regulation
 
ANTI-HYeeeeeeeeeesPERGLYCAEMIC DRUGS.pptx
ANTI-HYeeeeeeeeeesPERGLYCAEMIC DRUGS.pptxANTI-HYeeeeeeeeeesPERGLYCAEMIC DRUGS.pptx
ANTI-HYeeeeeeeeeesPERGLYCAEMIC DRUGS.pptx
 
Anti diabetic drugs
Anti diabetic drugsAnti diabetic drugs
Anti diabetic drugs
 
Diabetes Basics
Diabetes BasicsDiabetes Basics
Diabetes Basics
 
Insulin and antidiabetics
Insulin and antidiabeticsInsulin and antidiabetics
Insulin and antidiabetics
 
insulinandantidiabetics-160328194408.pdf
insulinandantidiabetics-160328194408.pdfinsulinandantidiabetics-160328194408.pdf
insulinandantidiabetics-160328194408.pdf
 
Insulin
Insulin Insulin
Insulin
 
Insulin physiology and biochemical effects by Dr Shahjada Selim
Insulin physiology and biochemical effects by Dr Shahjada SelimInsulin physiology and biochemical effects by Dr Shahjada Selim
Insulin physiology and biochemical effects by Dr Shahjada Selim
 

Más de MD Specialclass (20)

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutrition
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headaches
 
Acute brain attack 911
Acute brain attack  911Acute brain attack  911
Acute brain attack 911
 
Hema intro anemia
Hema intro anemiaHema intro anemia
Hema intro anemia
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
Fever & id diet final
Fever & id diet finalFever & id diet final
Fever & id diet final
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disorders
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Thyroid
ThyroidThyroid
Thyroid
 
Dermatology dr.n.ramos
Dermatology   dr.n.ramosDermatology   dr.n.ramos
Dermatology dr.n.ramos
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitis
 
Pancreatic disease
Pancreatic diseasePancreatic disease
Pancreatic disease
 
Liver disease
Liver diseaseLiver disease
Liver disease
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosis
 

Antidiabetic agents1dated

  • 1. Anti-diabetic Agents Florencia D. Munsayac, MD, FPSECP, MBA, RMT
  • 2.  
  • 3.
  • 4.
  • 5.
  • 6. Diabetes – Insulin (synthesis, storage, secretion) This light micrograph of a section of the human pancreas shows one of the islets of Langerhans, center, a group of modified glandular cells. These cells secrete insulin, a hormone that helps the body metabolize sugars, fats, and starches. The blue and white lines in the islets of Langerhans are blood vessels that carry the insulin to the rest of the body.
  • 7. Diabetes – Insulin (synthesis, storage, secretion) Insulin is a small protein consisting of an A chain of 21 amino acids linked by two disulfide (S—S) bridges to a B chain of 30 amino acids. Beta cells have channels in their plasma membrane that serve as glucose detectors. Beta cells secrete insulin in response to a rising level of circulating glucose .
  • 8.
  • 9. Diabetes – Insulin (synthesis, storage, secretion)
  • 10.
  • 11.
  • 12.
  • 13.
  • 14. Effects of Insulin on its Targets Transporters Tissues GlucoseKm (Mmo/L) Function GLUT 1 All tissues, esp.red cells, brain 1-2 Basal uptake of glucose; Transport across the BBB GLUT 2 B cells of pancreas; Liver; kidney; gut 15-20 Regulation of insulin release, other aspects of glucose homeostasis GLUT 3 Brain, kidney, placenta, other tissues < 1 Uptake into neurons, other tissues GLUT 4 Muscle, adipose 5 Insulin-mediated uptake of glucose GLUT 5 Gut, kidney 1-2 Absorption of fructose
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.  
  • 23.
  • 24.
  • 25. Insulin Delivery Systems   A.  Portable Pen Injectors - to facilitate multiple SQ injections   B. Continuous Subcutaneous Insulin Infusion Devices (CSII, Insulin Pumps) - encouraged for individuals who are unable to obtain target control while on multiple injection regimens & where excellent glycemic control is desired, such as during pregnancy - velosulin (reg. insulin) & insulin aspart and lispro   C.   Inhaled Insulin - have a rapid route and a relatively short duration of action - used to cover mealtime insulin requirements - to correct high glucose levels  
  • 26. Factors that Affect Insulin Absorption: -      site of injection: abdomen, buttock, anterior thigh, or dorsal arm -      type of insulin -      subcutaneous blood flow: massage, hot baths, or exercise -      smoking -      regional muscular activity at the site of the injection -      volume & concentration of injected insulin -      depth of injection  
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71.  
  • 72.
  • 73.  
  • 74.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84.
  • 86.
  • 87.
  • 88.  

Notas del editor

  1. Thank you…